Analyse microbiologique de plus de 600 infections urinaires fébriles prises en charge dans un réseau de soin

Bruyère, F.; Vidoni, María Rosa Scaramuzza; Péan, Y.; Ruimy, J.; Elfassi, Raphael

doi:10.1016/j.purol.2013.03.009

Cited by 11 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…C3G are on the other hand very active on this bacterium, only 9% of the strains were producers of extended spectrum beta-lactamases. This rate is close to that recorded at the HMIMV in Rabat [28], (9.4%), at the HMA in Marrakech [26], and Sfax (9.4%) [27], and higher than that ofFrance (2.5%) [25], .The strains isolated from urine in our study have a higher rate of resistance to Fluoroquinolones than those recorded in France (4.2%) [25],however the results described by other studies have been confirmed by our data. Our study also showed a resistance rate of 46% for the combination Trimethopirim+sulfamethoxazole.…”

Section: Discussionsupporting

confidence: 88%

“…Our study also showed a resistance rate of 46% for the combination Trimethopirim+sulfamethoxazole. The rate of resistance to this molecule varies between 20.1% (in France) [25], and 63.86% (in Dakar) [24],High resistance for Nitrofurantoine in the Nouakchott laboratories (38.9%) [23], while it is very low in the other studies where the rate of resistance varies between 1% and 5.5%. Whereas in our study this rate is around 1%.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Health vigilance concerning female urinary tract infections: Epidemiological profile and antibiotic resistance

et al. 2021

View full text Add to dashboard Cite

The objectives of our work were to establish the epidemiological and bacteriological profile of female urinary tract infection at the Mohammed VI University Hospital of Oujda (Morocco), and then to study the drug resistance of the bacterial strains isolated. This is a retrospective study over 36 months including urine samples from patients hospitalized or consulting at the CHU Mohamed VI of Oujda (Morocco). Urines were processed according to the recommendations of the Medical Microbiology Reference (REMIC) and the EUCAST (European Committee on Antimicrobial Susceptibility Testing). We collected 12556 requests for CBEU from different departments. At the top of the list was the emergency department with a rate of 37% (n= 4666) followed by outpatient clinics (33.1%; n=4226). 5% (n=630) of the CBEU were positive. Escherichia coli (E. coli ) dominated the epidemiological profile with a rate of 72.50% (n=482). E. coli was resistant to penicillins in 69.50% (n=299) of cases, protected penicillins in 34.80% (n=149), third generation cephalosporins (C3G) in 9% (n=38), fluoroquinolones in 17.5% (n=73), Trimethoprim-Sulfamethoxazole in 46% (n=196) of cases and gentamicin in 12% (n=51) of cases. None of the strains were resistant to carbapenems. Awareness-raising on the proper use of antibiotics, issuing national recommendations for the treatment of urinary tract infections in order to standardize therapeutic regimens. Effective control of these infections requires a global prevention strategy that implies close collaboration between epidemiologists, clinicians, bacteriologists, hygienists and the health care team.

show abstract

Section: Discussionsupporting

confidence: 88%

Section: Discussionmentioning

confidence: 99%